Collaborative Stage Data Set - Revised 08/07/2013 FINAL
Code | Description | TNM 7 Map | TNM 6 Map | SS77 Map | SS2000 Map |
000 | In situ, intraepithelial, noninvasive, preinvasive | TX | Tis | IS | IS |
100 | Invasive cancer tumor confined to corpus uteri | ^ | * | ** | ** |
110 | Confined to endometrium (stroma) | ^ | * | ** | ** |
114 | OBSOLETE DATA REVIEWED V0203 See codes 100, 110, 116, 120, 130-400, 510-530 Tumor 5 cm or less in greatest dimension | T1a | T2NOS | ** | ** |
116 | FIGO Stage IA | ^ | * | ** | ** |
120 | Tumor invades less than one-half of myometrium Invasion of inner half of myometrium | ^ | * | ** | ** |
124 | OBSOLETE DATA REVIEWED V0203 See code 100, 110, 120, 126-400, 510-530 Tumor greater than 5 cm | T1b | T2NOS | ** | ** |
126 | FIGO Stage IB | ^ | * | ** | ** |
130 | Tumor invades one-half or more of myometrium Invasion of outer half of myometrium (See Note 3) | ^ | * | ** | ** |
140 | Invasion of myometrium, NOS | ^ | * | ** | ** |
160 | Tunica serosa of the visceral peritoneum (serosa covering the corpus) | ^ | * | ** | ** |
400 | Localized, NOS | ^ | * | ** | ** |
500 | OBSOLETE DATA CONVERTED V0203 See code 523 Cervix uteri, NOS, but not beyond uterus | ERROR | ERROR | ERROR | ERROR |
510 | Endocervical glandular involvement only | ^ | * | RE | RE |
520 | Cervical stromal invasion | ^ | * | RE | RE |
523 | Cervix uteri, NOS, but not beyond uterus | ^ | * | RE | RE |
530 | FIGO Stage I [NOS] | ^ | * | ** | ** |
540 | Tumor limited to uterus, NOS | T1NOS | * | ** | ** |
550 | Adnexal involvement, NOS Extension or metastasis beyond uterus within pelvis: Adnexa Fallopian tube(s) Ligaments: Broad Round Uterosacral Ovary(ies) Parametrium Visceral peritoneum of pelvic organs excluding serosa of corpus uteri | T2a | T3a | RE | RE |
600 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 160, 550, 655, 665, and 688 Adnexal involvement, NOS Extension or metastasis within true pelvis: Adnexa Fallopian tube(s) Ligaments: Broad, round, uterosacral Ovary(ies) Parametrium Pelvic serosa Tunica serosa (parietal lining of the pelvic or abdominal cavity) | T2a | T3a | RE | RE |
605 | FIGO Stage IIA | T2a | T3a | RE | RE |
610 | OBSOLETE DATA RETAINED V0200 See Note 4 and CS Site Specific Factor 2 Cancer cells in ascites Cancer cells in peritoneal washings FIGO Stage IIIA | ERROR | T3a | RE | RE |
620 | OBSOLETE DATA CONVERTED V0203 See code 645 Ureter Vulva | ERROR | ERROR | ERROR | ERROR |
640 | Extension or metastasis to vagina | T2b | T3b | D | RE |
645 | Extension to : Ureter Vulva | T2b | T3b | D | RE |
650 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See code 655 and 662 Extension or metastasis to pelvic wall(s) Described clinically as "frozen pelvis", NOS | T2b | T3b | RE | RE |
655 | Extension or metastasis to: Pelvic wall(s) Parietal serosa of pelvic cavity | T2b | T3b | RE | RE |
660 | OBSOLETE DATA CONVERTED V0203 See code 705 Extension or metastasis to: Bladder wall Bladder, NOS excluding mucosa Rectal wall Rectum, NOS excluding mucosa | ERROR | ERROR | ERROR | ERROR |
662 | Described clinically as "frozen pelvis", NOS | T2b | T3b | D | RE |
663 | (655 or 662) + (640 or 645) | T2b | T3b | D | RE |
665 | Extension or metastasis to: Cul de sac (rectouterine pouch) | T2b | T3b | D | D |
670 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 663 and 705 [(650) or (660)] and [(620) or (640)] | T2b | T3b | D | RE |
675 | FIGO Stage IIB | T2b | T3b | RE | RE |
680 | OBSOLETE DATA CONVERTED V0203 See code 683 FIGO Stage II [NOS] | ERROR | ERROR | ERROR | ERROR |
682 | Extension beyond uterus, within pelvis, NOS | T2NOS | T3NOS | RE | RE |
683 | FIGO Stage II [NOS] | T2NOS | T3NOS | RE | RE |
685 | OBSOLETE DATA REVIEWED V0203 See codes 665 and 688 Contiguous extension to abdominal tissues, one of the following sites: Abdominal serosa (peritoneum) Cul de sac Sigmoid colon Small intestine Other abdominal tissues | T3a | T4 | D | D |
688 | Infiltration of abdominal tissues, one of the following sites: Abdominal serosa (visceral or parietal peritoneum of abdomen) Sigmoid colon Small intestine Other abdominal tissues | T3a | T4 | D | D |
690 | FIGO Stage IIIA | T3a | T4 | D | D |
692 | OBSOLETE DATA REVIEWED V0203 See codes 665 and 693 Contiguous extension to abdominal tissues, more than one site: Abdominal serosa (peritoneum) Cul de sac Sigmoid colon Small intestine Other abdominal tissues | T3b | T4 | D | D |
693 | Infiltration of abdominal tissues in code 688, more than one site | T3b | T4 | D | D |
694 | FIGO Stage IIIB | T3b | T4 | D | D |
696 | OBSOLETE DATA CONVERTED V0203 See code 699 FIGO Stage III [NOS] | ERROR | ERROR | ERROR | ERROR |
698 | Abdominal tissues involvement, NOS | T3NOS | T4 | D | D |
699 | FIGO Stage III [ NOS] | T3NOS | T4 | D | D |
700 | OBSOLETE DATA CONVERTED V0200 See code 710 Extension to bowel mucosa or bladder mucosa (excluding bullous edema) FIGO Stage IVA FIGO Stage IV, NOS | ERROR | ERROR | ERROR | ERROR |
705 | Invasion of: Bladder wall Bladder, NOS excluding mucosa Rectal wall Rectum, NOS excluding mucosa | T4 | T3b | RE | RE |
708 | 705 + (688, 693, or 698) Invasion of organs in code 705 plus infiltration of any abdominal tissues | T4 | T3b | D | D |
710 | OBSOLETE DATA REVIEWED AND CHANGED V0203 See codes 715, 720, 730 Extension to bowel mucosa or bladder mucosa (excluding bullous edema) Note: On conversion of code 700 to 710, code 710 also included FIGO Stage IVA, FIGO Stage IV, NOS | ERROR | ERROR | ERROR | ERROR |
715 | Extension to bowel mucosa or bladder (excluding bullous edema) | T4 | T4 | D | D |
720 | FIGO Stage IVA | T4 | T4 | D | D |
730 | FIGO Stage IV [NOS] | T4 | T4 | D | D |
800 | OBSOLETE DATA RETAINED AND REVIEWED V0203 See codes 665, 688, 693, and 850 Further contiguous extension Abdominal serosa (peritoneum) Cul de sac Sigmoid colon Small intestine (See codes 685 and 693 if number of involved sites is reported) | T3NOS | T4 | D | D |
850 | Further contiguous extension | T4 | T4 | D | D |
950 | No evidence of primary tumor | T0 | T0 | U | U |
999 | Unknown; extension not stated Primary tumor cannot be assessed Not documented in patient record | TX | TX | U | U |